EU | pharmaphorum

EU

News

The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.

News

Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.

News

The INTERCEPT trial aims to validate biomarkers that could identify people at risk of Crohn's and see if treatment can prevent symptoms developing.

News

Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.

News

Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.

News

Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure